Actuate Therapeutics Forecast, price target & analysts
$7.98
9.73%
yesterday
Nasdaq,
Dec 30, 10:00 pm CET
Actuate Therapeutics Target price 2024 - Analyst rating & recommendation
Powered by
Actuate Therapeutics Classifications & Recommendation:
Buy
100%
Actuate Therapeutics Price Target
| Target Price | $20.00 |
| Price | $7.98 |
| Potential |
150.63%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Actuate Therapeutics price target 2025.
The average Actuate Therapeutics target price is $20.00.
This is
150.63%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Actuate Therapeutics to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Actuate Therapeutics stock has an average upside potential 2025 of
150.63%
register free of charge
|
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
